Search Results

Baxter Recognized Globally for Inclusion Efforts

Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced today that it has been recognized by the Global Inclusion Index in 11 countries for its inclusion efforts. Baxter Brazil, China, France, Germany, India, Ireland, Italy, Japan, Mexico, Singapore and the UK earned spots on the inaugural Index.

Living Well with Kidney Disease

An estimated 850 million people have kidney disease globally; nearly 10.5 million of these individuals require dialysis or a kidney transplant.1 Each of these remarkable people have a story, a family and an adventure ahead of them; they deserve to live well with kidney disease.

Baxter Appoints Dr. David Wilkes to Its Board and Albert Stroucken as Lead Independent Director

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced it has appointed David S. Wilkes, M.D., dean, University of Virginia School of Medicine, and co-founder and chief scientific officer of biotech start-up ImmuneWorks Inc., to its board of directors. Dr. Wilkes will serve on Baxter's Quality, Compliance and Technology Committee. Additionally, Baxter has appointed Albert P.L.

Baxter Reports Fourth-Quarter and Full-Year 2020 Results

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the fourth quarter and full year ended December 31, 2020, and provided its financial guidance for 2021. 

Baxter Reports Second-Quarter 2020 Results

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the second quarter of 2020 and provided its outlook for full-year 2020. 

Baxter Declares Quarterly Dividend

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that its Board of Directors has declared a quarterly cash dividend of $0.245 per share of common stock. The dividend is payable on October 1, 2020, to shareholders of record as of August 31, 2020. The indicated annual dividend rate is $0.98 per share of common stock.  About Baxter

Baxter Publishes 2019 Corporate Responsibility Report, Highlighting Efforts to Make a Meaningful Difference as a Leading Global Corporate Citizen

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today released its 2019 Corporate Responsibility Report.

Baxter Senior Leadership Team Commitment to Addressing Racial Injustice

Our focus on Inclusion & Diversity (I&D) at Baxter has never been more compelling or urgent. Racism has been a longstanding and disturbing societal issue, and recent displays of racial injustice toward the Black community have rocked U.S. society to its core – with the impact resonating far beyond. The events are all the worse for playing out against a pandemic that’s compounding health and economic disparities globally.

Baxter Reports First-Quarter 2020 Results

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the first quarter of 2020. 

Baxter Shares Progress on Increasing Dialysis Supplies for Critically Ill COVID-19 Patients

Baxter International Inc., a global leader in acute care, today shared updates regarding its efforts to increase supply of critically needed dialysis products around the globe. The company is seeing demand up to five times greater than historical levels for multiple acute dialysis products as a result of an extraordinary rise in COVID-19 patients requiring access to continuous renal replacement therapy (CRRT).